Unick Fix-A-Form And Printers Ltd Experiences Revision in Stock Evaluation Amid Record Highs

Dec 10 2024 10:50 AM IST
share
Share Via
Unick Fix-A-Form And Printers Ltd has recently achieved an all-time high stock price, marking a significant milestone for the microcap company in the pharmaceuticals sector. MarketsMojo has made a revision in its score for the stock, reflecting its strong performance over the past year, significantly outpacing the sector. Despite some erratic trading patterns, Unick Fix-A-Form And Printers has shown resilience, consistently trading above key moving averages. The stock has also been added to MarketsMojo's list, highlighting its potential in the current market landscape.
Unick Fix-A-Form And Printers Ltd, a microcap player in the pharmaceuticals and drugs sector, has recently achieved a remarkable milestone by reaching an all-time high stock price of Rs.92 on December 10, 2024. This achievement is particularly significant as it marks a 3.16% outperformance against the broader sector on the same day.

Despite the current stock call from MarketsMOJO indicating a 'Sell' recommendation, Unick Fix-A-Form And Printers has demonstrated impressive growth over the past year, boasting a 53.33% increase, significantly outpacing the Sensex's 16.82% rise during the same period. This performance underscores the company's resilience and potential in a competitive market.

In recent trading sessions, the stock has exhibited some volatility, with no trading activity recorded on two separate days. However, it opened today with a notable gain of 3.37%, reaching an intraday high of Rs.92. The stock has maintained this price level consistently, indicating a stable trading environment.

Additionally, Unick Fix-A-Form And Printers is showing strong performance in relation to its moving averages, trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This trend suggests a positive outlook for the company's stock performance.

In a recent development, Unick Fix-A-Form And Printers has been added to MarketsMOJO's list, reflecting a revision in its evaluation. This addition highlights the stock's potential and the growing interest from investors, further emphasizing its noteworthy position within the pharmaceuticals and drugs industry. As the company continues to navigate the market landscape, its recent achievements and performance indicators will be closely monitored by analysts and investors alike.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News